Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04674813
Title A Study of CC-95266 in Subjects With Relapsed and/or Refractory Multiple Myeloma
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Juno Therapeutics, a Subsidiary of Celgene
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Local Institution - 005 Birmingham Alabama 10016 United States Details
Local Institution - 009 Duarte California 91010-301 United States Details
Local Institution - 012 San Francisco California 94143 United States Details
Local Institution - 002 Denver Colorado 80218 United States Details
Local Institution - 008 Baltimore Maryland 21201 United States Details
Local Institution - 010 Boston Massachusetts 02115 United States Details
Local Institution - 011 New York New York 10029 United States Details
Local Institution - 001 Nashville Tennessee 37203 United States Details
Local Institution - 006 Dallas Texas 75390 United States Details
Local Institution - 003 Seattle Washington 98104 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field